Xilio Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for XLO, updated each market day.
XLO AI Sentiment
AI sees no strong directional signal for Xilio Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 22, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Xilio Therapeutics, Inc. Common Stock
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Sector
Exchange
Market Cap
$59,484,583
Cap Tier
Employees
76
Headquarters
WALTHAM, MA
Listed Since
Oct. 22, 2021
Website
XLO Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
XLO Volatility
Xilio Therapeutics, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
